# The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Amendment) Regulations 2021, Regulation 2: Amendment of regulation 2 of the PLPS Regulations


In regulation 2(1) of the PLPS Regulations (interpretation), at the appropriate place insert—
““prescription item” means an item available on prescription, whether or not it is supplied in pursuance of a prescription or another basis for supply (for example a serious shortage protocol or a patient group direction);”; and
““PTPGD” means a pandemic treatment patient group direction, which is a patient group direction—
(a) relating to the supply of a prescription only medicine to be used for the prevention of or as a treatment for a disease that is, or in anticipation of it being imminently, pandemic; and
(b) which is in accordance with regulation 233 of the Human Medicines Regulations 2012 (exemption for supply etc under a PGD by a person conducting a retail pharmacy business);”.

---
Source: https://www.legislation.gov.uk/uksi/2021/169/regulation/2 (the official version)
Page: https://openlegislation.uk/national-health-service-charges-and-pharmaceutical-and-local-pharmaceutical-services-coronavirus-amendment-regulations-2021/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

